6-chlorotacrine

Known as: 6-Cl-tacrine 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2017
012319962017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BACKGROUND 6-chlorotacrine is a cholinesterase inhibitor showing good inhibitory potential, even better than parent compound… (More)
Is this relevant?
2017
2017
AIM The influence of the dose on the ability of promising newly prepared reversible inhibitor of acetylcholinesterase (6… (More)
Is this relevant?
2017
2017
A novel series of 6-chlorotacrine-scutellarin hybrids was designed, synthesized and the biological activity as potential anti… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2014
2014
Optimization of an essentially inactive 3,4-dihydro-2H-pyrano[3,2-c]quinoline carboxylic ester derivative as acetylcholinesterase… (More)
  • table 2
Is this relevant?
2013
2013
Alzheimer's disease (AD) is a complex neurological disorder with multiple inter-connected factors playing roles in the onset and… (More)
Is this relevant?
2010
2010
Two novel families of dual binding site acetylcholinesterase (AChE) inhibitors have been developed, consisting of a tacrine or 6… (More)
Is this relevant?
2009
2009
Two isomeric series of dual binding site acetylcholinesterase (AChE) inhibitors have been designed, synthesized, and tested for… (More)
Is this relevant?
2008
2008
A novel series of donepezil-tacrine hybrids designed to simultaneously interact with the active, peripheral and midgorge binding… (More)
Is this relevant?
2005
2005
A new series of donepezil-tacrine hybrid related derivatives have been synthesised as dual acetylcholinesterase inhibitors that… (More)
Is this relevant?
1996
1996
Multiconfiguration thermodynamic integration was used to determine the relative binding strength of tacrine and 6-chlorotacrine… (More)
Is this relevant?